Depression in Parkinson's disease - A review

Acta Neurologica Scandinavica

Volumn 113, Issue 1, 2006, Pages 1-8

  Lieberman, A ^a,b  

^a Lieberman Parkinson Clinic   (United States)

^b Liberman Parkinson Clinic   (United States)

Author keywords

Depression; Dopamine; Parkinson's disease

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOXEPIN; FLUOXETINE; LEVODOPA; MIRTAZAPINE; MONOAMINE OXIDASE B INHIBITOR; NORTRIPTYLINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGITATION; ANXIETY DISORDER; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN REGION; COGNITION; COMA; CONFUSION; DELUSION; DIARRHEA; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DROWSINESS; FEVER; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; INSOMNIA; LIMBIC SYSTEM; MAJOR DEPRESSION; MUSCLE SPASM; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PREVALENCE; REM SLEEP; RESTLESSNESS; REVIEW; RIGIDITY; SEDATION; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; STUPOR; SUBSTANTIA NIGRA; SWEATING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

DEPRESSIVE DISORDER; HUMANS; PARKINSON DISEASE;

EID: 33645214386     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00536.x     Document Type: Review

References (86)

1. L eentjens AF Depression in Parkinson's disease: conceptual issues and clinical challenges J Geriatric Psychiatry Neurol 2004 17 120 1206
2. C eravolo NA C eravolo R P icinni A Psychiatric co-morbidity in a population of Parkinson's disease patients Eur J Neurol 2004 11 315 20
3. B urn DJ Depression in Parkinson's disease Eur J Neurol 2002 9 44 54
4. Z esiewicz TA H auser RA Depression in patients with Parkinson's disease epidemiology, pathophysiology and treatment options CNS Drugs 2000 13 253 64
5. M ayberg HS S olomon DH Depression in Parkinson's disease. A biochemical and organic viewpoint Adv Neurol 1995 65 49 60
6. B rooks DJ D oder M Depression in Parkinson's disease Curr Opin Neurol 2001 14 465 70
7. C ummings JL Depression and Parkinson's disease: a review Am J Psychiatry 1992 149 443 54
8. O ertel WH H oglinger GU C araceni T Depression in Parkinson's disease. An update Adv Neurol 2001 86 373 83
9. American Psychiatric Association Statistical manual of mental disorders 4th edn Washington, DC American Psychiatric Association 1994
10. B urn DJ Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease Mov Disord 2002 17 445 54
11. E dwards E K itt C O liver E Depression and Parkinson's disease: a new look at an old problem Depress Anxiety 2002 16 39 48
12. L ieberman AN Depression in Parkinson's disease Barrow Neurol Inst Quart 1997 3 27 33
13. H ughes AJ D aniel SE K ilford L Accuracy of clinical diagnosis of idiopathic Parkinson's disease: clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 1992 55 181 5
14. K essler RC B erglund P D emler O National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 2003 289 3095 105
15. H amilton M Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 1967 6 278 96
16. L eentjens AF V erhey FR L ousberg R The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease Int J Geriatr Psychiatry 2000 15 644 9
17. L ieberman AN L yons K O kun M Depression on Parkinson's disease. Mental dysfunctions in Parkinson's disease In Korczyn AD ed Medimond International Proceedings
18. C ummings JL The Neuropsychiatric Inventory: assessing psychopathology in dementia patients Neurology 1997 48 S10 6
19. S laughter JR S laughter KA N ichols D Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease J Neuropsychiatry Clin Neurosci 2001 13 187 96
20. M enza MA M ark MH Parkinson's disease and depression: the relationship to disability and personality J Neuropsychiatry Clin Neurosci 1994 6 165 9
21. G iladi N T reves TA P aleacu D Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease J Neural Transm 2000 107 59 71
22. N ilsson FM K essing LV B olwig TG Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study Acta Psychiatr Scand 2001 104 380 6
23. N ilsson FM K essing LV S orensen TM Major depressive disorder in Parkinson's disease: a register-based study Acta Psychiatr Scand 2002 106 202 11
24. L eentjens AF V an den Akker M M etsemakers JF Higher incidence of depression preceding the onset of Parkinson's disease: a register study Mov Disord 2003 18 414 8
25. R ichard IH S chiffer RB K urlan R Anxiety and Parkinson's disease J Neuropsychiatry Clin Neurosci 1996 8 383 92
26. de R ijk C B ijl RV Prevalence of mental disorders in persons with Parkinson's disease Ned Tijdschr Geneeskd 1998 142 27 31
27. S hulman LM T aback RL B ean J Co-morbidity of the non-motor symptoms of Parkinson's disease Mov Disord 2001 16 507 10
28. S hiba M B ower JH M araganore DM Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study Mov Disord 2000 15 669 77
29. W eisskopf MG C hen H S chwarzschild MA Prospective study of phobic anxiety and risk of Parkinson's disease Mov Disord 2003 18 646 51
30. S iemers ER S hekhar A Q uaid K Anxiety and motor performance in Parkinson's disease Mov Disord 1993 8 501 6
31. M aricle RA N utt JG V alentine RJ Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study Neurology 1995 45 1757 60
32. R ichard IH J ustus AW K urlan R Relationship between mood and motor fluctuations in Parkinson's disease J Neuropsychiatry Clin Neurosci 2001 13 35 41
33. R audino F Non motor off in Parkinson's disease Acta Neurol Scand 2001 104 312 5
34. T essitore A H ariri AR F era F Dopamine modulates the response of the human amygdala: a study in Parkinson's disease J Neurosci 2002 22 99 103
35. H arding AJ S timson E H enderson JM Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease Brain 2002 125 2431 45
36. D el T redici K R ub U D e V os RA Where does parkinson disease pathology begin in the brain J Neuropathol Exp Neurol 2002 61 413 26
37. J elling KA Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution - a pilot study Acta Neuropathol (Berl) 2003 106 191 201
38. R obert PH C lairet S B enoit M The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment Int J Geriatr Psychiatry 2002 17 1099 105
39. P luck GC B rown RG Apathy in Parkinson's disease J Neurol Neurosurg Psychiatry 2002 73 636 42
40. L evy ML C ummings JL F airbanks LA Apathy is not depression J Neuropsychiatry Clin Neurosci 1998 10 314 9
41. C ummings JL Frontal-subcortical circuits and human behavior Arch Neurol 1993 50 873 80
42. M olina JA S ainz -A rtiga MJ F raile A Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment Mov Disord 2000 15 869 72
43. D river -D unckley E S amanta J S tacy M Pathological gambling associated with dopamine agonist therapy in Parkinson's disease Neurology 2003 61 422 3
44. K urlan R Disabling repetitive behaviors in Parkinson's disease Mov Disord 2004 19 433 7
45. G iovannoni G O 'Sullivan JD T urner K Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies J Neurol Neurosurg Psychiatry 2000 68 423 8
46. I kemoto S P anksepp J The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking Brain Res Brain Res Rev 1999 31 6 41
47. W illner P L appas S C heeta S Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole Psychopharmacology (Berl) 1994 115 454 62
48. H ughes TA R oss HF M usa S A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease Neurology 2000 54 1596 602
49. H obson P M eara J Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom Mov Disord 2004 19 1043 9
50. L ieberman A Point of view: dementia in Parkinson's disease Parkinsonism Relat Disord 1997 3 151 8
51. M arsh L W illiams JR R occo M Psychiatric co-morbidities in patients with Parkinson disease and psychosis Neurology 2004 63 293 300
52. A lexander GE D e L ong MR S trick PL Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu Rev Neurosci 1986 9 357 81
53. H appe S S chrodl B F altl M Sleep disorders and depression in patients with Parkinson's disease Acta Neurol Scand 2001 104 275 80
54. T andberg E L arsen JP K arlsen K A community-based study of sleep disorders in patients with Parkinson's disease Mov Disord 1998 13 895 9
55. O erlemans WG de W eerd AW The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey Sleep Med 2002 3 147 9
56. C omella CL N ardine TM D iederich NJ Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease Neurology 1998 51 526 9
57. S chenck CH B undlie SR M ahowald MW Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder Neurology 1996 46 388 93
58. T orack RM M orris JC The association of ventral tegmental area histopathology with adult dementia Arch Neurol 1988 45 497 501
59. M ann JJ K apur S A dopaminergic hypothesis of major depression Clin Neuropharmacol 1995 18 S57 65
60. W illner P The mesolimbic dopamine system as a target for rapid antidepressant action Int Clin Psychopharmacol 1997 12 S7 14
61. F ahn S L ibsch LR C utler RW Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor J Neurol Sci 1971 14 427 55
62. C han -P alay V A san E Alterations in catecholamine neurons of the locus ceruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression J Comp Neurol 1989 287 373 92
63. N agatsu T Y amaguchi T R ahman MK Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extra-pyramidal diseases Adv Neurol 1984 40 467 73
64. A nderson KE M ullins J Behavioral changes associated with deep brain stimulation surgery for Parkinson's disease Curr Neurol Neurosci Rep 2003 3 306 13
65. B ejjani BP D amier P A rnulf I Transient acute depression induced by high-frequency deep-brain stimulation N Engl J Med 1999 340 1476 80
66. F unkieweiz A C aputo E A rdouin C Behavioral and mood changes associated with bilateral stimulation of the subthalamic nucleus: a consecutive series of 98 Parkinsonian patients Neurology 2001 56 274 9
67. W oods SP F ields JA T roster AI Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review Neuropsychol Rev 2002 12 111 26
68. K opell BH G reenberg B R ezai AR Deep brain stimulation for psychiatric disorders J Clin Neurophysiol 2004 21 51 67
69. L aitinen LV S ingounas E Intraoperative electrical stimulation of the brain in patients with obsessive-compulsive neurosis Appl Neurophysiol 1988 51 317 23
70. M allet L M esnage V H oueto JL Compulsions, Parkinson's disease, and stimulation Lancet 2002 360 1302 4
71. A bkevich V C amp NJ H ensel CH Predisposition locus for major depression at chromosome 12q22-12q23.2 Am J Hum Genet 2003 73 1271 81
72. D egner D G rohmann R K ropp S Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP Pharmacopsychiatry 2004 37 S39 45
73. Parkinson Study Group Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. Parkinson Study Group JAMA 2000 284 1931 8
74. R ascol O B rooks DJ K orczyn AD A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa N Engl J Med 2000 342 1484 91
75. C ummings JL D-3 receptor agonists: combined action neurologic and neuropsychiatric agents J Neurol Sci 1999 163 2 3
76. R ektorova I R ektor I B ares M Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study Eur J Neurol 2003 10 399 406
77. G uttman M J askolka J The use of pramipexole in Parkinson's disease: are its actions D(3) mediated Parkinsonism Relat Disord 2001 7 231 4
78. S zegedi A H illert A W etzel H Pramipexole, a dopamine agonist, in major depression: antidepressant effects and tolerability in an open-label study with multiple doses Clin Neuropharmacol 1997 20 S36 45
79. S porn J G haemi SN S ambur MR Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review Ann Clin Psychiatry 2000 12 137 40
80. C orrigan MH D enahan AQ W right CE Comparison of pramipexole, fluoxetine, and placebo in patients with major depression Depress Anxiety 2000 11 58 65
81. B urn DJ M c K eith IG Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease Mov Disord 2003 18 S72 9
82. R itter JL A lexander B Retrospective study of selegiline-antidepressant drug interactions and a review of the literature Ann Clin Psychiatry 1997 9 7 13
83. R ichard IH K urlan R T anner C Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group Neurology 1997 48 1070 7
84. R oth T R ye DB B orchert LD Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists Sleep Med 2003 4 275 80
85. H ening WA A llen RP E arley CJ An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder Sleep 2004 27 560 83
86. A dler CH H auser RA S ethi K Ropinirole for restless legs syndrome: a placebo-controlled crossover trial Neurology 2004 62 1405 7